FOLH1 and neoplasm: The cycle-to-cycle variability of 37.8% (CV) on the tumor uptake rate (k14) was hypothesized to play a part in [177Lu]Lu-PSMA-I&T PK based on previously reported results for [177Lu]Lu-PSMA-617, where a somewhat higher CV was found of 43.5% [24].